出版社:American Society for Biochemistry and Molecular Biology
摘要:Fibrates are widely used hypolipidemic drugs that regulate the expression of many genes involved in lipid metabolism by activating the peroxisome proliferator-activated receptor α (PPARα). The objective of this study was to investigate the mechanism of action of peroxisome proliferators and PPARα on the transcription of cholesterol 7α-hydroxylase, the rate-limiting enzyme in the conversion of cholesterol to bile acids in the liver. When cotransfected with the expression vectors for PPARα and RXRα, Wy14,643 reduced human and rat cholesterol 7α-hydroxylase gene ( CYP7A1 )/luciferase reporter activities by 88% and 43%, respectively, in HepG2 cells, but not in CV-1 or CHO cells. We have mapped the peroxisome proliferator response element (PPRE) to a conserved sequence containing the canonical AGGTCA direct repeats separated by one nucleotide (DR1). This DR1 sequence was mapped previously as a binding site for the hepatocyte nuclear factor 4 (HNF-4) which stimulates CYP7A1 transcription. Electrophoretic mobility shift assay (EMSA) showed no direct binding of in vitro synthesized PPARα/RXRα heterodimer to the DR1 sequence. PPARα and Wy14,643 did not affect HNF-4 binding to the DR1. However, Wy14,643 and PPARα/RXRα significantly reduced HNF-4 expression in HepG2 cells. These results suggest that PPARα and agonist repress cholesterol 7α-hydroxylase activity by reducing the availability of HNF-4 for binding to the DR-1 sequence and therefore attenuates the transactivation of CYP7A1 by HNF-4. —Marrapodi, M., and J. Y. L. Chiang. Peroxisome proliferator-activated receptor α (PPARα) and agonist inhibit cholesterol 7α-hydroxylase gene ( CYP7A1 ) transcription. J. Lipid Res. 2000. 41: 514–520.